Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (61)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Albertella, M. R.
Right arrow Articles by Duncan Campbe, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albertella, M. R.
Right arrow Articles by Duncan Campbe, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

OTHER

Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins

REPORTS

Mark R. Albertella and R. Duncan Campbe*

MRC Immunochemistry Unit, Department of Biochemistry, Oxford University South Parks Road, Oxford OX1 3QU, UK

Received ; Accepted March 3, 1994

At least 110 genes are now known to be located In the 4000 kb of ONA encompassing the human major histocompatiblllty complex (MHC) in the chromosome band 6p21.3. Recent genomic sequence analysis of a 90 kb segment of DNA containing the tumour necrosis factor genes in the class III region of the MHC has predicted the presence of three potential exons mapping between the BAT1 and TNFB genes (12). A near full-length cDNA clone corresponding to a novel gene located between BAT1 and TNFB that contains sequence corresponding to one of these putative exons, has been isolated from a premonocytic leukaemic cell line cDNA library. Characterization of this gene reveals that it spans 13.5 kb of DNA, with the 3‘ end of the gene lying {small tilde} 12 kb from the 5’ end of the TNFB gene. The cDNA hybridizes to a {small tilde} 1.6 kb mRNA in a number of different cell types, including monocytes, T cells, B cells and hepatocytes. The putative polypeptide encoded by this cDNA is 381 amino acids in length, with a non-glycosylated Mr of 43214. It contains one partial and two full ANK repeats, which bear a marked similarity to those In the I kappa B family of proteins, suggesting that the protein encoded by the novel gene could represent a divergent member of this family.


*To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. H. Atkinson, K. A. Rockett, G. Morgan, P. A. Bejon, G. Sirugo, M. A. O'Connell, N. Hanchard, D. P. Kwiatkowski, and A. M. Prentice
Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children
Blood, November 15, 2008; 112(10): 4276 - 4283.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. M. Taylor, K. Wicks, C. Vandiedonck, and J. C. Knight
Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements
Nucleic Acids Res., September 1, 2008; 36(15): 4845 - 4862.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. Greetham, C. D. Ellis, D. Mewar, U. Fearon, S. N. a. Ultaigh, D. J. Veale, F. Guesdon, and A. G. Wilson
Functional characterization of NF-{kappa}B inhibitor-like protein 1 (NF{kappa}BIL1), a candidate susceptibility gene for rheumatoid arthritis
Hum. Mol. Genet., December 15, 2007; 16(24): 3027 - 3036.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. Boonyasrisawat, D. Eberle, S. Bacci, Y.-Y. Zhang, D. Nolan, E. V. Gervino, M. T. Johnstone, V. Trischitta, S. E. Shoelson, and A. Doria
Tag Polymorphisms at the A20 (TNFAIP3) Locus Are Associated With Lower Gene Expression and Increased Risk of Coronary Artery Disease in Type 2 Diabetes
Diabetes, February 1, 2007; 56(2): 499 - 505.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Nasuhara, I. M. Adcock, M. Catley, P. J. Barnes, and R. Newton
Differential Ikappa B Kinase Activation and Ikappa Balpha Degradation by Interleukin-1beta and Tumor Necrosis Factor-alpha in Human U937 Monocytic Cells. EVIDENCE FOR ADDITIONAL REGULATORY STEPS IN kappa B-DEPENDENT TRANSCRIPTION
J. Biol. Chem., July 9, 1999; 274(28): 19965 - 19972.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Neville and R. D. Campbell
A New Member of the Ig Superfamily and a V-ATPase G Subunit Are Among the Predicted Products of Novel Genes Close to the TNF Locus in the Human MHC
J. Immunol., April 15, 1999; 162(8): 4745 - 4754.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. M. Attar, H. Macdonald-Bravo, C. Raventos-Suarez, S. K. Durham, and R. Bravo
Expression of Constitutively Active Ikappa Bbeta in T Cells of Transgenic Mice: Persistent NF-kappa B Activity Is Required for T-Cell Immune Responses
Mol. Cell. Biol., January 1, 1998; 18(1): 477 - 487.
[Abstract] [Full Text]


Home page
BloodHome page
J. R. Gruen and S. M. Weissman
Evolving Views of the Major Histocompatibility Complex
Blood, December 1, 1997; 90(11): 4252 - 4265.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. G. Wilson, J. A. Symons, T. L. McDowell, H. O. McDevitt, and G. W. Duff
Effects of a polymorphism in the human tumor necrosis factor alpha  promoter on transcriptional activation
PNAS, April 1, 1997; 94(7): 3195 - 3199.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ray, D.-H. Zhang, J. A. Elias, and A. Ray
Cloning of a Differentially Expressed I[IMAGE]B-related Protein
J. Biol. Chem., May 5, 1995; 270(18): 10680 - 10685.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.